Dr. Mohammad Saeed was invited to present his research on the ‘Genetics of MHC-I-Opathy’ at the British Society for Rheumatology (BSR) (April 24, 2024). The summary of the research was published in the official BSR Journal, Rheumatology.
The presentation was well-received by the august audience of Rheumatologists and Immunologists at the BSR 2024. A lengthy follow-up meeting was held at the University of Leeds and a collaboration for data and analysis exchange was established with Dr. Mohammad Saeed. University of Leeds has been recognized as a center of excellence in Rheumatology by EULAR (European League against Rheumatism) since 2005.
This research received no funding to perform. However, participation at the BSR 2024 Meeting was sponsored by High-Q and KIAZEN Pharmaceuticals, Pakistan. This was considered Advertising campaign for the Sponsors and declared at the BSR Meeting Oral Presentation.
